U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Resources for You (Drugs)
  4. Drug Information for Consumers
  5. Buying & Using Medicine Safely
  6. Medication Health Fraud
  7. Public Notification: The Silver Bullet contains hidden drug ingredients
  1. Buying & Using Medicine Safely

Public Notification: The Silver Bullet contains hidden drug ingredients

Public Notification: The Silver Bullet contains hidden drug ingredients

[[1-10-2019] The Food and Drug Administration is advising consumers not to purchase or use The Silver Bullet, a product promoted for sexual enhancement and sold on various websites, including www.ebay.com, and possibly in some retail stores.

FDA laboratory analysis confirmed that The Silver Bullet contains sildenafil and tadalafil, the active ingredients in the FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. These undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Health care professionals and patients should report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:Image of The Silver Bullet

Note: This notification is to inform the public of products marketed as dietary supplements or conventional foods with hidden drug ingredients and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories. 

For more information:

Contact FDA

Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information

Division of Drug Information (CDER)

Office of Communications

Feedback Form

10001 New Hampshire Avenue

Hillandale Building, 4th Floor

Silver Spring, MD 20993